HCP Program · CHAPEL HILL, NC · Sep 12, 2026

Join Us for

AN EVENING OF PEER-TO-PEER EDUCATION

For decades, cardiometabolic medicine has treated the river — the hypertension, the dyslipidemia, the diabetes — and rarely the rain. In a single year, the ACC, ADA, and AHA have converged on a different position: obesity is the upstream driver, and treating it directly is treating cardiovascular-kidney-metabolic disease at its source.

Event Details · Chapel Hill, NC

Sep 3, 2026

Date & Time

Sep 12

2026 · 6:30pm – 9:00pm CT

Doors open at 6:00pm

Location

Venue TBD

Chapel Hill, NC

Directions provided upon registration

Format

  • Dinner provided
  • Expert presentation (~45 min)
  • Peer discussion
  • Q&A
  • 15–20 HCPs · Intimate setting

Keynote Presenter · A Personal Invitation

Treat Obesity First: A Mandate to Improve the Quality of Obesity Care

We’re confirming our speaker for the event. This will be a nationally recognized expert in cardiovascular medicine, metabolic disease, or obesity management — check back soon for the full profile and bio.

Get notified when speaker is announced

Untitled(Required)
By clicking SUBMIT, you agree that you are 18 years or older and agree to the Viking Therapeutics Terms of Use. You understand and agree that the information you provided will be used in accordance with the Viking Therapeutics Privacy Policy, including to provide you with marketing information, offers, and promotions, and to contact you for your opinions regarding products, programs, and services. You understand that unless you unsubscribe by calling (858) 704-4660 or clicking unsubscribe in a promotional email, your consent will remain valid.

September 2, 2026 · WAKE FOREST

Program Overview

#

CATEGORY

dETAILS

AT A GLANCE

DETAILS

01

Structure

Program Format

KOL-led dinner program · Dinner · Peer discussion · Q&A

  • 15–20 HCPs
  • Dinner provided
  • ~2 hrs

02

Curriculum

What’s Covered

Topic: Current guidelines in obesity management and cardiometabolic impact

An engaging evening with peers to review the latest guidelines, including obesity-first treatment guidance, and patient dialogue starters.

  • [TBD]

03

Audience

Who Should Attend

Cardiologists · PCPs· Endocrinologists · Obesity medicine specialists · NPs & PAs · Pharmacists

  • All specialties
  • NPs & PAs welcome
  • Invite colleagues

Why This Matters

Your Patients Are at Risk. This Conversation Can Help.

Obesity and cardiovascular disease intersect in nearly every practice. This program equips you with the clinical evidence, guideline updates, and peer perspectives to act with more confidence.

1 in 3

US adults live with obesity

— CDC

42%

of people with obesity have CVD risk factors

— AHA

74%

of cardiometabolic patients are undertreated

— JACC

1 in 3

US adults live with obesity

— CDC

42%

of people with obesity have CVD risk factors

— AHA

74%

of cardiometabolic patients are undertreated

— JACC

LOCAL Partners & Resources

RESERVE YOUR SEAT

Attendance is limited to ensure an intimate learning experience. Seats fill quickly, so register today.

COMMON QUESTIONS

Frequently Asked Questions

Is this a Viking Therapeutics product launch or promotional event?

No. The HCP program is an unbranded peer-to-peer educational dinner on cardiovascular risk and metabolic disease, led by a KOL. The content addresses the broader treatment landscape including current guidelines and evidence on GLP-1 receptor agonists. Sponsorship is disclosed; promotional content is not delivered during the educational portion.

Will materials be available after the event?

No. The HCP program is an unbranded peer-to-peer educational dinner on cardiovascular risk and metabolic disease, led by a KOL. The content addresses the broader treatment landscape including current guidelines and evidence on GLP-1 receptor agonists. Sponsorship is disclosed; promotional content is not delivered during the educational portion.

Can I bring colleagues?

No. The HCP program is an unbranded peer-to-peer educational dinner on cardiovascular risk and metabolic disease, led by a KOL. The content addresses the broader treatment landscape including current guidelines and evidence on GLP-1 receptor agonists. Sponsorship is disclosed; promotional content is not delivered during the educational portion.

What is the dress code?

No. The HCP program is an unbranded peer-to-peer educational dinner on cardiovascular risk and metabolic disease, led by a KOL. The content addresses the broader treatment landscape including current guidelines and evidence on GLP-1 receptor agonists. Sponsorship is disclosed; promotional content is not delivered during the educational portion.

ALSO IN CHAPEL HILL

Keep your Know Your Score experience going

For Patients & Caregivers

Community Event

Interactive community event on weight and health. Open to everyone — patients, caregivers, families.